Results 1 to 10 of about 7,699,553 (352)
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee [PDF]
Osong Public Health and Research Perspectives, 2023 With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events.
Na-Young Jeong +10 more
doaj +1 more source
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Communications Medicine, 2021 Coutinho et al. use genomic and epidemiological data from Manaus, Brazil, to estimate the transmissibility and potential for reinfection with the SARS-CoV-2 variant-of-concern P.1 (gamma).
Renato Mendes Coutinho +14 more
doaj +1 more source
The World Health Organization COVID-19 surveillance database
International Journal for Equity in Health, 2022 In January 2020, SARS-CoV-2 virus was identified as a cause of an outbreak in China. The disease quickly spread worldwide, and the World Health Organization (WHO) declared the pandemic in March 2020. From the first notifications of spread of the disease,
Maya Allan +10 more
doaj +1 more source
Ensuring trust in COVID-19 data
Medicine, 2021 There are no standardized methods for collecting and reporting coronavirus disease-2019 (COVID-19) data. We aimed to compare the proportion of patients admitted for COVID-19-related symptoms and those admitted for other reasons who incidentally tested ...
Daniel Antwi-Amoabeng +7 more
semanticscholar +1 more source
A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
BMC Infectious Diseases, 2022 Background To improve understanding of the antibody response to SARS-CoV-2 infection, we examined seroprevalence, incidence of infection, and seroconversion among a cohort of young adults living on university campuses during the fall of 2020.
Christine C. Lee +23 more
doaj +1 more source
BMC Infectious Diseases, 2023 Background University students commonly received COVID-19 vaccinations before returning to U.S. campuses in the Fall of 2021. Given likely immunologic variation among students based on differences in type of primary series and/or booster dose vaccine ...
Peter M. DeJonge +24 more
doaj +1 more source
Diagnosis and Management of COVID-19 Disease [PDF]
, 2020 SARS-CoV-2 is a novel coronavirus that was identified in late 2019 as the causative agent of COVID-19 (aka coronavirus disease 2019). On March 11, 2020, the World Health Organization (WHO) declared the world-wide outbreak of COVID-19 a pandemic.
Carlos, Graham +5 more
core +1 more source
Nature Communications, 2021 Transmission by pre-symptomatic and asymptomatic viral carriers makes intervention and containment of the COVID-19 extremely challenging. Here, the authors construct an epidemiological model that focuses on transmission around the symptom onset ...
Liang Tian +11 more
doaj +1 more source
Countries with delayed COVID-19 introduction – characteristics, drivers, gaps, and opportunities
Globalization and Health, 2021 Background Three months after the first reported cases, COVID-19 had spread to nearly 90% of World Health Organization (WHO) member states and only 24 countries had not reported cases as of 30 March 2020. This analysis aimed to 1) assess characteristics,
Zheng Li +11 more
doaj +1 more source
COVID-19 and chronological aging : senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? [PDF]
, 2020 COVID-19, also known as SARS-CoV-2, is a new emerging zoonotic corona virus of the SARS (Severe Acute Respiratory Syndrome) and the MERS (Middle East Respiratory Syndrome) family.
Auwerx +30 more
core +2 more sources